Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

RB 13/2026 Zmiana terminu publikacji raportu okresowego za pierwszy kwartał 2026 roku

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.